1. Bioretec signed a distribution agreement to accelerate commercialization of the RemeOs trauma screw system in the U.S.
2. Three-year data for the Discseel spine procedure found it was effective and could replace most spine surgeries.
3. Theradaptive earned the FDA’s investigational device exemption approval to broaden its clinical research for the OsteoAdapt SP implant.
4. A clinical trial out of the University of California San Diego School of Medicine found that neural stem cell transplantation had shown long-term safety and feasibility for treating chronic spinal cord injuries.
5. Columbus, Ohio-based Atreon Orthopedics completed 10,000 rotator cuff repair surgeries with the use of its Rotium bioresorbable wick.
6. Medtronic and Kuros Biosciences signed a strategic agreement to support sales of the MagnetOs bone graft technology.
7. Ventris Medical earned FDA 510(k) clearance for its Backpack bone graft containment system.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
